- Markets
- FMCG
- AJOONI
AJOONI
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Ajooni Biotech Appoints 300+ Dealers And Distributors In India
Jan 20 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
APPOINTS 300+ DEALERS AND DISTRIBUTORS IN INDIA
ENTERS B2C MARKET
Source text: ID:nNSE9ydQ5x
Further company coverage: AJOO.NS
(([email protected];;))
Jan 20 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
APPOINTS 300+ DEALERS AND DISTRIBUTORS IN INDIA
ENTERS B2C MARKET
Source text: ID:nNSE9ydQ5x
Further company coverage: AJOO.NS
(([email protected];;))
Ajooni Biotech To Raise 450 Million Rupees Via Convertible Warrants
Jan 6 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH - TO RAISE 450 MILLION RUPEES VIA CONVERTIBLE WARRANTS
Source text: ID:nNSE2mnFYm
Further company coverage: AJOO.NS
(([email protected];))
Jan 6 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH - TO RAISE 450 MILLION RUPEES VIA CONVERTIBLE WARRANTS
Source text: ID:nNSE2mnFYm
Further company coverage: AJOO.NS
(([email protected];))
Ajooni Biotech To Issue Warrants Of Upto 450 Million Rupees
Jan 3 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH - TO ISSUE WARRANTS OF UPTO 450 MILLION RUPEES
Source text: ID:nNSE2SDWBQ
Further company coverage: AJOO.NS
(([email protected];))
Jan 3 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH - TO ISSUE WARRANTS OF UPTO 450 MILLION RUPEES
Source text: ID:nNSE2SDWBQ
Further company coverage: AJOO.NS
(([email protected];))
Ajooni Biotech Receives Repeat Order From Avon Animal Health For Cattle Feed Supplements
Oct 23 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
RECEIVED REPEAT ORDER FROM AVON ANIMAL HEALTH FOR CATTLE FEED SUPPLEMENTS
Source text for Eikon: ID:nNSE9W2N1G
Further company coverage: AJOO.NS
(([email protected];;))
Oct 23 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
RECEIVED REPEAT ORDER FROM AVON ANIMAL HEALTH FOR CATTLE FEED SUPPLEMENTS
Source text for Eikon: ID:nNSE9W2N1G
Further company coverage: AJOO.NS
(([email protected];;))
Ajooni Biotech Enters Gujarat Market For Supply Of Cattle Feed
July 23 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH LTD - ENTERED GUJARAT MARKET FOR SUPPLY OF CATTLE FEED
Source text for Eikon: [ID:]
Further company coverage: AJOO.NS
(([email protected];))
July 23 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH LTD - ENTERED GUJARAT MARKET FOR SUPPLY OF CATTLE FEED
Source text for Eikon: [ID:]
Further company coverage: AJOO.NS
(([email protected];))
Ajooni Biotech Gets Order Worth 49.5 Million Rupees
July 1 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
GETS ORDER WORTH 49.5 MILLION RUPEES
Further company coverage: AJOO.NS
(([email protected];))
July 1 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
GETS ORDER WORTH 49.5 MILLION RUPEES
Further company coverage: AJOO.NS
(([email protected];))
Ajooni Biotech Says Avalon And Ajooni Interested In Working Together As Partners
June 18 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AVALON AND AJOONI INTERESTED IN WORKING TOGETHER AS PARTNERS FOR AGRI-PROCESSING COMPONENT OF MORINGA PROJECT
AJOONI AGREED TO WORK ON PROJECTS AS STAKEHOLDER IN SIMILAR PROJECTS BEING DEVELOPED BY AVALON ENERGY GROUP
Further company coverage: AJOO.NS
(([email protected];))
June 18 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AVALON AND AJOONI INTERESTED IN WORKING TOGETHER AS PARTNERS FOR AGRI-PROCESSING COMPONENT OF MORINGA PROJECT
AJOONI AGREED TO WORK ON PROJECTS AS STAKEHOLDER IN SIMILAR PROJECTS BEING DEVELOPED BY AVALON ENERGY GROUP
Further company coverage: AJOO.NS
(([email protected];))
Ajooni Biotech Gets Export Order From Avon Animal Health
May 20 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH LTD - GETS EXPORT ORDER FROM AVON ANIMAL HEALTH
AJOONI BIOTECH LTD - SIGNED CONTRACT AGREEMENT WITH NATIONAL DAIRY DEVELOPMENT BOARD (NDDB)- DAIRY SERVICES
AJOONI BIOTECH LTD - AJOONI BIOTECH PARTNERS WITH UAMMCL
Source text for Eikon: ID:nNSE5yKhC8
Further company coverage: AJOO.NS
(([email protected];))
May 20 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AJOONI BIOTECH LTD - GETS EXPORT ORDER FROM AVON ANIMAL HEALTH
AJOONI BIOTECH LTD - SIGNED CONTRACT AGREEMENT WITH NATIONAL DAIRY DEVELOPMENT BOARD (NDDB)- DAIRY SERVICES
AJOONI BIOTECH LTD - AJOONI BIOTECH PARTNERS WITH UAMMCL
Source text for Eikon: ID:nNSE5yKhC8
Further company coverage: AJOO.NS
(([email protected];))
Ajooni Biotech Says Avon Animal Health Interested In Purchasing Cattle Feed Supplements From Co
April 22 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AVON ANIMAL HEALTH INTERESTED IN PURCHASING CATTLE FEED SUPPLEMENTS FROM CO
RECEIVED SECOND ORDER FROM AVON ANIMAL HEALTH
Source text for Eikon: ID:nNSE8l3hYN
Further company coverage: AJOO.NS
(([email protected];))
April 22 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
AVON ANIMAL HEALTH INTERESTED IN PURCHASING CATTLE FEED SUPPLEMENTS FROM CO
RECEIVED SECOND ORDER FROM AVON ANIMAL HEALTH
Source text for Eikon: ID:nNSE8l3hYN
Further company coverage: AJOO.NS
(([email protected];))
India's Ajooni Biotech reports March-Quarter Net Profit Versus Loss Year Ago
May 18 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
MARCH-QUARTER NET PROFIT 5.4 MILLION RUPEES VERSUS LOSS 613,000 RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 412.6 MILLION RUPEES VERSUS 205.1 MILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: AJOO.NS
(([email protected];))
May 18 (Reuters) - Ajooni Biotech Ltd AJOO.NS:
MARCH-QUARTER NET PROFIT 5.4 MILLION RUPEES VERSUS LOSS 613,000 RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 412.6 MILLION RUPEES VERSUS 205.1 MILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: AJOO.NS
(([email protected];))
Events:
Rights
Rights
Split
Bonus
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Ajooni Biotech do?
Ajooni Biotech Limited is a leading manufacturer and supplier of high-quality veterinary products such as Patanjali Samvriddhi and Patanjali Garbhanjali. Their products are known for hygiene, accurate composition, and effectiveness.
Who are the competitors of Ajooni Biotech?
Ajooni Biotech major competitors are Prima Industries, Prima Agro, Waterbase, Godrej Agrovet, KSE, Godrej Industries, Zeal Aqua. Market Cap of Ajooni Biotech is ₹105 Crs. While the median market cap of its peers are ₹213 Crs.
Is Ajooni Biotech financially stable compared to its competitors?
Ajooni Biotech seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Ajooni Biotech pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ajooni Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ajooni Biotech allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Short Term Loans & Advances
How strong is Ajooni Biotech balance sheet?
Balance sheet of Ajooni Biotech is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Ajooni Biotech improving?
Yes, profit is increasing. The profit of Ajooni Biotech is ₹2.73 Crs for TTM, ₹2.16 Crs for Mar 2024 and ₹1.12 Crs for Mar 2023.
Is the debt of Ajooni Biotech increasing or decreasing?
The debt of Ajooni Biotech is decreasing. Latest debt of Ajooni Biotech is -₹15.53 Crs as of Dec-24. This is less than Mar-24 when it was ₹1.52 Crs.
Is Ajooni Biotech stock expensive?
Ajooni Biotech is not expensive. Latest PE of Ajooni Biotech is 38.58, while 3 year average PE is 69.55. Also latest EV/EBITDA of Ajooni Biotech is 21.05 while 3yr average is 27.27.
Has the share price of Ajooni Biotech grown faster than its competition?
Ajooni Biotech has given better returns compared to its competitors. Ajooni Biotech has grown at ~4.42% over the last 7yrs while peers have grown at a median rate of -4.36%
Is the promoter bullish about Ajooni Biotech?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Ajooni Biotech is 26.89% and last quarter promoter holding is 26.89%.
Are mutual funds buying/selling Ajooni Biotech?
There is Insufficient data to gauge this.